St John Ambulance launches defibrillators to boost bystander rescues
17 February, 2021St John Ambulance has launched two groundbreaking defibrillators to improve bystander participation during sudden cardiac arrest emergencies.
Skeletal age calculator predicts fracture risk
16 February, 2021Researchers have developed a model that predicts the biological age of bones, estimating an individual's risk of bone fracture and premature death.
Partnership delivers smart, reusable PPE solutions
15 February, 2021RFiD Discovery and Welspring have partnered to offer high-quality, reusable and trackable protective garments for frontline healthcare workers.
Long-lasting infection-control solution now available in Australia
12 February, 2021SurfaceWise2, a hospital-grade disinfectant that makes surfaces hostile to germs for up to three months, has been launched in Australia by Allied BioServices.
Vaccine rollout may face delays
11 February, 2021 by Amy SarcevicInsufficient manufacturing infrastructure and incorrect handling after dispatch are creating supply shortfalls and wastage around the world.
Russian Sputnik vaccine demonstrates 91.6% efficacy
08 February, 2021Preliminary results from the Russian COVID-19 phase 3 vaccine trial suggest that the two-dose vaccine regimen is 91.6% efficacious against symptomatic COVID-19.
Aus biotech company supplies at-home COVID-19 tests to US
05 February, 2021 by Lauren DavisQueensland-based company Ellume has announced a US$231.8 million (AU$302.7 million) agreement to accelerate domestic US production of its COVID-19 home tests.
Active ingredient prescribing comes into effect
04 February, 2021 by Matthew Grant, Monash UniversityDoctors must now prescribe drugs using their chemical name, not brand names. That's good news for patients.
Novavax vaccine demonstrates 89.3% efficacy
03 February, 2021Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.
ANPC develops new COVID-19-detecting technology
03 February, 2021A patent has been filed for advanced magnetic resonance technology that can detect the pathological signature of COVID-19 without relying on direct detection of the SARS-CoV-2 virus.
Blood cancer burden on the rise
03 February, 2021Blood cancers are now the second most diagnosed cancers in Australia and the second most common cause of cancer-related deaths, according to the Leukaemia Foundation.
COVID-19 may reduce male fertility
01 February, 2021A German study indicates that COVID-19 infection can cause increased sperm cell death, inflammation and oxidative stress, resulting in lower sperm quality and potentially reducing fertility.
Monash innovation reduces risk of COVID in healthcare workers
29 January, 2021A Monash University study reveals that a simple ventilated headboard hood can stop SARS-CoV-2 from spreading between patients and healthcare workers on hospital wards.
Study predicts global cancer surgery surge
27 January, 2021A modelling study led by UNSW Sydney predicts that global demand for cancer surgery will rise by 52% within two decades, with low-income countries bearing the greatest burden.
黑料吃瓜群网 pharmacists prepare for vaccine rollout
27 January, 2021With COVID-19 vaccinations set to roll out in less than one month, Australia's hospital pharmacists are preparing for their central role in the administration process.
